A. Chaturvedi

发表

Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.

S. Wacholder, M. Sherman, W. Quint, 2011, The Journal of infectious diseases.

Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

P. Hartge, M. Sherman, L. Brinton, 2014, Gynecologic oncology.

Determination of virulence factors of Escherichia coli isolated from urinary tract infection patients

A. Chaturvedi, V. Singh, A. Gautam, 2014 .

Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association.

Alonso Carrasco-Labra, Elliot Abt, Mark W. Lingen, 2017, Journal of the American Dental Association.

Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association.

E. Abt, A. Chaturvedi, M. Lingen, 2017, Journal of the American Dental Association.

Risk of human papillomavirus-associated cancers among persons with AIDS.

R. Biggar, A. Chaturvedi, E. Engels, 2009, Journal of the National Cancer Institute.

Oral Tongue Cancers: Pooled Analysis from the INHANCE Association of Marijuana Smoking with Oropharyngeal and Updated version

H. Morgenstern, K. Straif, A. Olshan, 2014 .

Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial

P. Hartge, C. Guillemette, M. Sherman, 2017, International journal of cancer.

Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study

J. P. McCoy, R. Pfeiffer, A. Chaturvedi, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Study the incidence of Bacillus cereus isolates from dairy foods

A. Chaturvedi, V. Singh, S. Shukla, 2015 .

A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.

M. Bottai, A. Chaturvedi, E. Munck‐Wikland, 2015, European journal of cancer.

Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

P. Hall, S. Fosså, F. Langmark, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Life-GainedBased Versus Risk-Based Selection of Smokers for Lung Cancer Screening

C. Berg, P. Castle, A. Chaturvedi, 2019, Annals of Internal Medicine.

Evaluating Discrimination of a Lung Cancer Risk Prediction Model Using Partial Risk-Score in a Two-Phase Study

N. Chatterjee, A. Chaturvedi, Parichoy Pal Choudhury, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Contemporary Implications of U.S. Preventive Services Task Force and Risk-Based Guidelines for Lung Cancer Screening Eligibility in the United States

C. Berg, A. Chaturvedi, H. Katki, 2019, Annals of Internal Medicine.

Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 20052015

A. Jemal, C. Berg, A. Chaturvedi, 2018, Annals of Internal Medicine.

Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus‐infected individuals in the United States

A. Chaturvedi, C. Lynch, E. Engels, 2018, Cancer.

A snapshot of the evolving epidemiology of oropharynx cancers

A. Chaturvedi, Z. Zumsteg, 2018, Cancer.

Burden of HPV-positive oropharynx cancers among ever and never smokers in the U.S. population.

A. Chaturvedi, H. Katki, M. Gillison, 2016, Oral oncology.

Elevated risk of lung cancer among people with AIDS

J. Goedert, R. Pfeiffer, R. Biggar, 2007, AIDS.

Circulating inflammation markers and colorectal adenoma risk.

N. Rothman, S. Berndt, N. Wentzensen, 2019, Carcinogenesis.

Targeting of low-dose CT screening according to the risk of lung-cancer death.

C. Berg, T. Riley, G. Silvestri, 2013, The New England journal of medicine.

Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States

C. Matthews, C. Abnet, N. Freedman, 2021, The American journal of gastroenterology.

OP-JNCI200215 1590..1594

C. Berg, A. Chaturvedi, H. Katki, 2021 .

OP-JNCI190046 996..999

C. Berg, A. Chaturvedi, H. Katki, 2019 .

Chronic Obstructive Pulmonary Disease and Altered Risk of Lung Cancer in a Population-Based Case-Control Study

S. Wacholder, J. Lubin, A. Goldstein, 2009, PloS one.

Lower Risk of Lung Cancer after Multiple Pneumonia Diagnoses

S. Wacholder, J. Lubin, A. Goldstein, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Pulmonary Infections and Risk of Lung Cancer Among Persons With AIDS

J. Goedert, F. Shebl, A. Chaturvedi, 2010, Journal of acquired immune deficiency syndromes.

Tonsillectomy and Risk of Oropharyngeal Cancer: Implications for Research and Prevention

A. Chaturvedi, 2015, Cancer Prevention Research.

High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.

B. Graubard, A. Chaturvedi, M. Gillison, 2014, The Journal of infectious diseases.

Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Esther Kim, Sean Altekruse, Philip S Rosenberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.

B. Graubard, A. Chaturvedi, M. Gillison, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Does a decline in tonsillectomies explain the rise in tonsil cancer incidence in recent years ?

A. Chaturvedi, 2015 .

HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS : SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING , NOVEMBER

A. Giuliano, A. Chaturvedi, W. Westra, 2009 .

HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING,

A. Giuliano, A. Chaturvedi, W. Westra, 2009 .

Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals.

P. Rosenberg, A. Chaturvedi, Z. Zumsteg, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.

A. Chaturvedi, A. Kreimer, Nicole G. Campos, 2021, Journal of the National Cancer Institute.

Incidence of potentially human papillomavirus–related neoplasms in the United States, 1978 to 2007

S. Devesa, A. Chaturvedi, G. Dores, 2013, Cancer.

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

A. Chaturvedi, W. Anderson, E. Engels, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HPV-associated Oropharyngeal Cancers—Are They Preventable?

A. Chaturvedi, A. Kreimer, 2011, Cancer Prevention Research.

Human papillomavirus genotypes among women with HIV: implications for research and prevention.

J. Goedert, A. Chaturvedi, 2006, AIDS.

Detection of Human Papillomavirus DNA in Urine Specimens from Human Immunodeficiency Virus-Positive Women

M. Hagensee, A. Chaturvedi, J. Clayton, 2002, Journal of Clinical Microbiology.

Cancer risk in persons with HIV/AIDS in India: a review and future directions for research

R. Biggar, A. Chaturvedi, K. Bhatia, 2009, Infectious Agents and Cancer.

Preventing Lung Cancer Mortality by Computed Tomography Screening: The Effect of Risk-Based Versus U.S. Preventive Services Task Force Eligibility Criteria, 2005–2015

Ahmedin Jemal, Hormuzd A. Katki, Anil K. Chaturvedi, 2018 .

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012

Jacques Ferlay, Ahmedin Jemal, A. Jemal, 2017, CA: a cancer journal for clinicians.

Oral leukoplakia and risk of progression to oral cancer: A population-based cohort study.

A. Chaturvedi, H. Katki, M. Lingen, 2019, Journal of the National Cancer Institute.

Oral cavity anatomical site image classification and analysis

Paul C. Pearlman, S. Antani, A. Chaturvedi, 2022, Medical Imaging.

Risk-Based Selection of Individuals for Oral Cancer Screening.

B. Graubard, A. Chaturvedi, H. Katki, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Industrial hog farming is associated with altered circulating immunological markers

A. Chaturvedi, A. Hildesheim, C. Lynch, 2017, Occupational and Environmental Medicine.

Automatic Detection of Oral Lesion Measurement Ruler Toward Computer-Aided Image-Based Oral Cancer Screening

Paul C. Pearlman, S. Antani, A. Chaturvedi, 2022, 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC).

Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors

N. Freedman, B. Graubard, P. Castle, 2022, Cancer.

Markers of microbial translocation and risk of AIDS-related lymphoma

J. Goedert, A. Chaturvedi, E. Engels, 2013, AIDS.

Representative oral microbiome data for the US population: the National Health and Nutrition Examination Survey.

E. Vogtmann, X. Hua, Jianxin Shi, 2022, The Lancet. Microbe.

Exclusive use of different types of tobacco products, exposure to secondhand tobacco smoke and risk of subtypes of head and neck cancer among Indian males

R. Dikshit, P. Chaturvedi, A. Chaturvedi, 2022, International journal of cancer.

Variation in Human Papillomavirus Vaccination Effectiveness in the US by Age at Vaccination

A. Chaturvedi, H. Katki, R. Landy, 2022, JAMA network open.

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?

A. Chaturvedi, R. Landy, 2021, EBioMedicine.

Herd Protection Against Oral HPV Infection-Reply.

B. Graubard, A. Chaturvedi, M. Gillison, 2020, JAMA.

Oral microbiome and risk of incident head and neck cancer: A nested case-control study.

E. Vogtmann, X. Hua, R. Sinha, 2023, Oral oncology.

OCCURANCE OF CLOSTRIDIUM SPECIES IN DIFFERENT DAIRY PRODUCTS AND ITS ASSOCIATED HEALTH RISK

A. Chaturvedi, S. Shukla, 2015 .

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Carole Fakhry, A. Chaturvedi, W. Anderson, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of spore forming Clostridium sporogenes in different dairy products and their industrial and public health significance

A. Chaturvedi, V. Singh, A. Gautam, 2015 .

Hematologic and biochemical changes associated with human T lymphotropic virus type 1 infection in Jamaica: a report from the population-based blood donors study.

A. Chaturvedi, H. Katki, B. Hanchard, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and Clustering Patterns of Human Papillomavirus Genotypes in Multiple Infections

Leann Myers, M. Hagensee, A. Chaturvedi, 2005, Cancer Epidemiology Biomarkers & Prevention.

Beyond cervical cancer: burden of other HPV-related cancers among men and women.

A. Chaturvedi, 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Optimization of PCR based detection of human papillomavirus DNA from urine specimens.

M. Hagensee, A. Chaturvedi, W. Jones, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012.

Wendy Cozen, Charles S. Coffey, R. Ferris, 2017, Oral oncology.

Cancer burden in the HIV-infected population in the United States.

J. Goedert, M. Gail, R. Pfeiffer, 2011, Journal of the National Cancer Institute.

J. Goedert, R. Biggar, A. Chaturvedi, 2007, Journal of the National Cancer Institute.

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

J. Goedert, E. Jaffe, R. Pfeiffer, 2006, Blood.

Burden of potentially human papillomavirus‐associated cancers of the oropharynx and oral cavity in the US, 1998–2003

S. Coughlin, M. Reichman, Xiaocheng Wu, 2008, Cancer.

Assessing the Burden of HPV-Associated Cancers in the United States HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and Women

D. Lowy, A. Chaturvedi, M. Gillison, 2008 .

Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.

L. Alemany, X. Castellsagué, P. Snijders, 2012, Vaccine.

Epidemiology and Clinical Aspects of HPV in Head and Neck Cancers

A. Chaturvedi, 2012, Head and Neck Pathology.

Prevalence of oral HPV infection in the United States, 2009-2010.

B. Graubard, A. Chaturvedi, M. Gillison, 2012, JAMA.

NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men.

B. Graubard, A. Chaturvedi, M. Gillison, 2015, Cancer research.

Dental opinion leaders’ perspectives on barriers and facilitators to HPV-related prevention

A. Chaturvedi, C. Vamos, E. Thompson, 2019, Human vaccines & immunotherapeutics.

Anthropometry and head and neck cancer:a pooled analysis of cohort data.

E. Riboli, P. Hartge, J. Buring, 2015, International journal of epidemiology.

Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.

Jacques Ferlay, Philip S Rosenberg, J. Ferlay, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI.

M. Carrington, F. Bray, S. Chanock, 2020, Oral oncology.

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Bingshu E. Chen, P. Hall, S. Fosså, 2007, Journal of the National Cancer Institute.

Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk

Jianxin Shi, S. Chanock, N. Chatterjee, 2012, Cancer.

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

R. Pfeiffer, A. Chaturvedi, H. Katki, 2015, Journal of the National Cancer Institute.

Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

N. Wentzensen, A. Chaturvedi, H. Katki, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Differential Serum Cytokine Levels and Risk of Lung Cancer Between African and European Americans

E. Bowman, C. Harris, A. Chaturvedi, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Selection criteria for lung-cancer screening.

Timothy R Church, Hormuzd A Katki, C. Berg, 2013, The New England journal of medicine.

Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C.

A. Giuliano, A. Chaturvedi, W. Westra, 2009, Head & neck.

Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix

S. Franceschi, M. Goodman, X. Castellsagué, 2014, International journal of cancer.

Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women.

M. Hagensee, A. Chaturvedi, P. Kissinger, 2004, The Journal of general virology.

Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-Sponsored Workshop

A. Chaturvedi, A. Hildesheim, M. Verma, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Human Papillomavirus-Specific Antibody Status in Oral Fluids Modestly Reflects Serum Status in Human Immunodeficiency Virus-Positive Individuals

M. Hagensee, A. Chaturvedi, J. Cameron, 2003, Clinical Diagnostic Laboratory Immunology.

Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly

M. Manos, A. Chaturvedi, H. Katki, 2015, Cancer Prevention Research.

Cigarette smoking and variations in systemic immune and inflammation markers.

J. Goedert, N. Freedman, N. Wentzensen, 2014, Journal of the National Cancer Institute.

Running head: Immune & inflammation markers and future NHL risk

N. Rothman, R. Pfeiffer, A. Chaturvedi, 2017 .

A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.

N. Rothman, R. Pfeiffer, Ju-Hyun Park, 2013, Blood.

risk of non-Hodgkin lymphoma A prospective study of 67 serum immune and inflammation markers and

N. Rothman, R. Pfeiffer, A. Chaturvedi, 2013 .

Assessment of Human Papillomavirus in Lung Tumor Tissue

S. Wacholder, A. Goldstein, P. Taylor, 2011, Journal of the National Cancer Institute.

Detection of HPV DNA in paraffin-embedded cervical samples: a comparison of four genotyping methods

C. Wheeler, M. Schiffman, W. Quint, 2015, BMC Infectious Diseases.

Circulating inflammation markers and prospective risk for lung cancer.

R. Pfeiffer, Ju-Hyun Park, A. Chaturvedi, 2013, Journal of the National Cancer Institute.

Impact of the HIV epidemic on the incidence rates of anal cancer in the United States.

R. Pfeiffer, A. Chaturvedi, A. Kreimer, 2012, Journal of the National Cancer Institute.

impact of the H iV epidemic on the incidence r ates of Anal c ancer in the United States

R. Pfeiffer, A. Chaturvedi, A. Kreimer, 2012 .

Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.

A. Chaturvedi, E. Engels, S. Mbulaiteye, 2008, Annals of epidemiology.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Leah E. Mechanic, E. Bowman, C. Harris, 2011, Journal of the National Cancer Institute.

Response: Re: Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

Heikki Joensuu, Eero Pukkala, Per Hall, 2008 .

Prevalence of Oral HPV Infection in Unvaccinated Men and Women in the United States, 2009-2016.

B. Graubard, A. Chaturvedi, M. Gillison, 2019, JAMA.

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

C. Harris, A. Chaturvedi, N. Caporaso, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients

G. Klintmalm, R. Pfeiffer, A. Chaturvedi, 2015, Cancer medicine.

Chlamydia pneumoniae Infection and Risk for Lung Cancer

J. Goedert, N. Chatterjee, A. Chaturvedi, 2004, Cancer Epidemiology, Biomarkers & Prevention.

Human Papillomavirus and Head and Neck Cancer

A. Chaturvedi, M. Gillison, 2010 .

Impact of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the U.S.

B. Graubard, A. Chaturvedi, M. Gillison, 2017 .

Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers

R. Sinha, S. Mayne, N. Freedman, 2015, Cancer Epidemiology, Biomarkers & Prevention.

A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai

N. Rothman, X. Shu, Y. Xiang, 2017, Carcinogenesis.

The Evolving Epidemiology of Oral Cavity and Oropharyngeal Cancers.

C. Abnet, N. Freedman, A. Chaturvedi, 2022, Cancer research.

Body Mass Index, Physical Activity, and Serum Markers of Inflammation, Immunity, and Insulin Resistance

N. Wentzensen, A. Chaturvedi, H. Katki, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium

H. Morgenstern, K. Straif, A. Olshan, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Invited commentary: circulating inflammation markers and cancer risk--implications for epidemiologic studies.

A. Chaturvedi, A. Hildesheim, S. Moore, 2013, American journal of epidemiology.

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Stephanie A Kovalchik, Hormuzd A Katki, C. Berg, 2016, JAMA.

Circulating Markers of Interstitial Lung Disease and Subsequent Risk of Lung Cancer

A. Chaturvedi, H. Katki, N. Caporaso, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Contribution of Demographic and Behavioral Factors on the Changing Incidence Rates of Oropharyngeal and Oral Cavity Cancers in Northern California

A. Chaturvedi, M. Silverberg, M. Merchant, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Contemporary impact of tobacco use on periodontal disease in the USA

E. Vogtmann, C. Abnet, N. Freedman, 2016, Tobacco Control.

Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines.

C. Berg, A. Chaturvedi, H. Katki, 2021, Journal of the National Cancer Institute.

Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening

A. Jemal, C. Berg, E. Jacobs, 2018, Annals of Internal Medicine.

Risk of Gastrointestinal Cancers among Patients with Appendectomy: A Large-Scale Swedish Register-Based Cohort Study during 1970-2009

A. Andrén-sandberg, C. Abnet, A. Chaturvedi, 2016, PloS one.

Response to Brandt, Bednarz-Knoll, Kleinheinz et al.

A. Chaturvedi, H. Katki, M. Lingen, 2020, Journal of the National Cancer Institute.

Incidence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US)

A. Chaturvedi, W. Anderson, E. Engels, 2007 .

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States

R. Pfeiffer, N. Wentzensen, A. Chaturvedi, 2017, PloS one.

C-reactive protein and risk of lung cancer.

J. Goedert, S. Chanock, N. Chatterjee, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result.

C. Berg, A. Chaturvedi, H. Katki, 2019, Journal of the National Cancer Institute.

Management of lung cancer screening results based on individual prediction of current and future lung cancer risk.

C. Berg, A. Chaturvedi, H. Katki, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Review article Beyond Cervical Cancer: Burden of Other HPV-Related Cancers Among Men and Women

A. Chaturvedi, 2010 .

Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.

Keegan D. Korthauer, M. Newton, M. Sherman, 2016, Carcinogenesis.

Reply to P.A. Leppäluoto

P. Hall, S. Fosså, F. Langmark, 2009 .

Table 2 . ORs and 95 % CIs for associations of lung cancer with pneumonia and tuberculosis diagnosed at least 1 y prior to entry into the EAGLE case-control study , both overall and stratified by smoking status

S. Wacholder, J. Lubin, A. Goldstein, 2010 .

Tumor-Based Case–Control Studies of Infection and Cancer: Muddling the When and Where of Molecular Epidemiology

S. Wacholder, A. Chaturvedi, H. Katki, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Development and validation of an individualized risk prediction model for oropharynx cancer in the US population

B. Graubard, A. Chaturvedi, H. Katki, 2019, Cancer.

Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study

B. Graubard, A. Chaturvedi, H. Katki, 2023, Journal of the National Cancer Institute.

Tonsillectomy and Incidence of Oropharyngeal Cancers

A. Chaturvedi, W. Anderson, W. Ye, 2016, Cancer Epidemiology, Biomarkers & Prevention.

The Current Burden of Oropharyngeal Cancer: A Global Assessment Based on GLOBOCAN 2020.

F. Bray, V. Lorenzoni, J. Vignat, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

P. Rosenberg, S. Altekruse, M. Goodman, 2014 .

Wear Characterization of Al/Ingredients MMFC

A. Chaturvedi, K. Chandra, P. Mishra, 2009 .

Comprehensive control of human papillomavirus infections and related diseases.

M. Plummer, M. Poljak, J. Ferlay, 2013, Vaccine.

Prevalence of human papillomavirus genotypes in women from three clinical settings

M. Hagensee, A. Chaturvedi, P. Kissinger, 2005, Journal of medical virology.

Burden of potentially human papillomavirus‐associated cancers of the oropharynx and oral cavity in the US, 1998–2003

S. Coughlin, M. Reichman, A. Giuliano, 2008, Cancer.

AJG-21-0243 1844..1852

C. Matthews, C. Abnet, N. Freedman, 2022 .

Circulating inflammation markers and prospective risk for lung cancer.

R. Pfeiffer, Ju-Hyun Park, A. Chaturvedi, 2013, Journal of the National Cancer Institute.

Evaluating discriminatory accuracy of models using partial risk-scores in two-phase studies

Nilanjan Chatterjee, Parichoy Pal Choudhury, Anil K. Chaturvedi, 2017, 1710.04379.

Global burden of human papillomavirus-positive head and neck cancers.

A. Chaturvedi, 2014, The Lancet. Oncology.